Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development of novel products for serious rare and ultra-rare ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Corporate News FDA Management Comments

Ultragenyx Pharma (RARE) PT Lowered to $66 at CitiAugust 5, 2019 6:26 AM Ultragenyx Pharma (RARE) Misses Q2 EPS by 2c, Revenues BeatAugust 1, 2019 5:39 PM Ultragenyx Announces Submission of New Drug Application to FDA for UX007 (triheptanoin) for Treatment of Long-Chain Fatty Acid Oxidation DisordersAugust 1, 2019 8:30 AM